For osteosarcoma, Tsukahara et al. reported papillomavirus binding factor (PBF) as human autologous osteosarcoma gene [27] and Tsuda et al. reported SART3 as a promising candidate for immunotherapy for osteosarcoma patients [28]. The gene discussed is SART3; the disease is osteosarcoma.